NDAQ Dec 2024 62.500 call
| Previous Close | 4.9000 |
| Open | 5.0000 |
| Bid | 4.5000 |
| Ask | 4.9000 |
| Strike | 62.50 |
| Expire Date | 2024-12-20 |
| Day's Range | 4.9000 - 5.0000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 49 |
GlobeNewswireNasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date May 15, 2024
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of May 15, 2024, short interest in 3,063 Nasdaq Global MarketSM securities totaled 11,646,612,058 shares compared with 11,683,381,571 shares in 3,072 Global Market issues reported for the prior settlement date of April 30, 2024. The mid-May short interest represents 3.15 days compared with 3.29 days for the prior reporting period. Short interest in 1,719 securities on The Nasdaq Capital MarketSM totaled 1,972,813,805 sh
IPO-Edge.comIPO Edge Fireside Chats at Nasdaq on June 11
IPO Edge will host fireside chats at Nasdaq MarketSite on Tuesday, June 11, 2024, from 2:00 pm until 3:00 pm at the state-of-the-art Studio A, home of the iconic daily […]
GlobeNewswireDelisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. from The Nasdaq Stock Market
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.’s securities were suspended on March 18, 2024, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the ordinary shares and warrants of Tritium DCFC Limited. Tritium DCFC Limited’s securities were suspended on April 22, 2024, and have not traded on Nasdaq since that time. Nasdaq als
